Research News
Q&A with Maria Barbolina, Ph.D.
Dr. Maria Barbolina is a 2013 Liz Tilberis Early Career Award grant recipient. In this interview with OCRF’s Sarah DeFeo, Dr. Barolina discusses her research and what it means to receive a grant from OCRF…
Ovarian Tissue Transplant followed by Successful IVF Creates Future Fertility Hope for Ovarian Cancer Survivors
An ovarian cancer survivor in Australia, Vali, is 26-weeks pregnant after being told she was infertile due to ovarian cancer treatments…
OCRF Researchers Find Some Immune Cells Aid Cancer Growth
A new OCRF-funded study from researchers at the University of Michigan Comprehensive Cancer Center found that a subset of immune cells, called myeloid derived suppressor cells, do more harm than good by providing a niche where the cancer stem cells…
Helq Gene Increases Risk of Rare Ovarian Cancer
Researchers in the UK have identified a gene in mice that, if faulty, may increase the chance of developing a rare type of ovarian cancer. The findings were published in the journal Nature…
New Index May Help to Determine Recurrence Risk
An index created at The University of Texas MD Anderson Cancer Center in Houston, based on protein biomarkers was able to discriminate between women at high risk and low risk for ovarian cancer recurrence, in a recent analysis…
Oncofertility Offers New Options for Young Women with Cancer
The Washington Post explores new options for young women going through cancer treatment who want to know about their options for having children after treatment…
Promising New Approach for Early Detection of Ovarian Cancer
Building on previously presented work, researchers at M.D. Anderson Cancer Center in Houston have published new findings that show that evaluating the change of CA-125 over time shows promise as a screening tool for early-stage ovarian cancer…
OCRF Researchers Review Preclinical Models Used in Ovarian Cancer Research
In a review article published online in Oncogene on August 12, OCRF-funded researchers provide a comprehensive review of pre-clinical models used in ovarian cancer research…
Dogs Smell Ovarian Cancer Tissue
Two dogs at the University of Pennsylvania’s Penn Vet Working Dog Center are learning how to smell tissue that is in early stages of ovarian cancer. The dogs have been able to smell the cancerous tissue 100% of the time…
Time Interval from Surgery to Chemo Impacts Prognosis in Ovarian Cancer
Researchers in Austria investigated whether the time interval from surgery to start of chemotherapy has an impact on clinical outcome in patients with advanced serous ovarian cancer…
Ovarian Cancer Therapies in Development
Dr. Coleman, a member of the Alliance’s Scientific and Medical Advisory Board, conducted an interview on ovarian cancer therapies for the Cancer Network…
Analysis Points to New Cell Lines as Tumor Models for Ovarian Cancer Research
Research published online last week in Nature Communications suggests that some of the cell lines most frequently used to study high-grade serous ovarian cancer (HGSOC) may not be the best…